Fundraising Fox
Cellibre
San Diego, US · Founded 2017 · Delaware corporation · 9 known investors
Find your way into Cellibre
73 people in our graph share verified history with the Cellibre team — schools, employers, funds. One of them is your warm intro.
Mina Mishrikeyunlockedknows Spiros Kambourakis · together at Cellibre (overlapped)
×7knows the team · via Syntheticgenomics
×4knows the team · via Codexis
Cellibre engineers biological manufacturing by programming cells to produce industrial products through fermentation rather than traditional chemical synthesis. The company serves manufacturers seeking sustainable, cost-effective production of chemicals, materials, and other goods using cellular factories.
Founders & leadership
Cellibre was founded in 2017 by Ben Chiarelli.
BC
Ben ChiarelliCEO
SK
Spiros KambourakisCo-founder and CTOSpiros Kambourakis is a biochemist and protein engineer with over 15 years of experience in enzyme discovery, biocatalysis, and the development of fermentation-based synthesis routes for industrial chemicals. He has led scientific teams and managed multiple projects bridging technical research and commercial development, with contributions to patent portfolios and product commercialization.
NC
Nicky CaiazzaNamed on SEC filing
Investors · 9
Dellin Investmentslisted by Dellin InvestmentsPhiladelphia
How we know: Dellin Investments's portfolio page · Not right? Tell us
Delta Emerald Ventureslisted by Delta Emerald Ventures
How we know: prnewswire.com · Not right? Tell us
Merida Capital Holdingslisted by Merida Capital HoldingsRye
How we know: prnewswire.com · Not right? Tell us
New Form CapitalreportedNew York
How we know: a partner's Signal profile · Not right? Tell us
Also in the syndicate · 2
Entourage Effect CapitalL2V
Reported raises · per SEC filings
Form D private placements$20.8M disclosed across 3 rounds · 2019–2024
▶$6.7MraisedOct 2024 · 31 investors · BiotechnologyRule 506(b)
▶$6.7MraisedOct 2024 · 31 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Nicky CaiazzaExecutive Officer, Director
- Scott ZingheimExecutive Officer, Director
- Spiros KambourakisExecutive Officer, Director
- Benjamin ChiarelliExecutive Officer, Director
- Offering amount
- $23.2M
- Amount sold
- $6.7M
- Minimum investment
- $521
- First sale
- Sep 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$9.9MraisedSep 2021 · 35 investors · BiotechnologyRule 506(b)
▶$9.9MraisedSep 2021 · 35 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Benjamin ChiarelliExecutive Officer, Director
- Scott ZingheimExecutive Officer, Director
- Nicky CaiazzaExecutive Officer, Director
- Spiros KambourakisExecutive Officer, Director
- Offering amount
- $15M
- Amount sold
- $9.9M
- Minimum investment
- $5K
- First sale
- Aug 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$4.2MraisedJul 2019 · 21 investors · BiotechnologyRule 506(b)
▶$4.2MraisedJul 2019 · 21 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Benjamin ChiarelliExecutive Officer
- Offering amount
- $5M
- Amount sold
- $4.2M
- Sales commissions
- $72K
- Placement agents
- Paradigm Capital U.S., Inc.
- First sale
- Jun 2019
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlap
Cellino Bio8 shared keywordsCellineobio develops cell engineering and bioprocess technology platforms. The company serves biotech and pharmaceutical research and manufacturing customers.
CellFE5 shared keywordsCellFE develops microfluidics technology and instrumentation for cell therapy manufacturing, serving biotech researchers and clinical teams. The company's platform enables more efficient and accessible production of cell therapies for treatment applications.
Companies competing with Cellibre for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Cellibre do?
- Cellibre engineers biological manufacturing by programming cells to produce industrial products through fermentation rather than traditional chemical synthesis. The company serves manufacturers seeking sustainable, cost-effective production of chemicals, materials, and other goods using cellular factories.
- Who founded Cellibre?
- Cellibre was founded by Ben Chiarelli in 2017.
- Who are Cellibre's investors?
- Cellibre's investors include Beresford Ventures, Dellin Investments, Delta Emerald Ventures, JourneyOne Ventures, Merida Capital Holdings, Flatiron Venture Partners, New Form Capital.
- How much funding has Cellibre raised?
- Cellibre has disclosed $20.8M raised across 3 rounds.
- Where is Cellibre headquartered?
- Cellibre is headquartered in San Diego, US.